ONIVIX
Live / Applied — Fifth extension granted (statement of use) (as of 03 Mar 2026)
What this means for you
Not registered yet, but its 29 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97388974
- Mark type
- Stylized text
- Filed
- 29 Apr 2022
- Published for opposition
- 21 Mar 2023
- Attorney of record
- Lori Wolfe
Goods and services
- Class 010 — Medical apparatus: Contraceptive device, namely, an intrauterine device
Owner
- TEVA PHARMACEUTICALS USA, Inc., Parsippany, NJ, US
- TEVA PHARMACEUTICALS USA, Inc., Parsippany, NJ, US
Prosecution history
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 5 GRANTED
- 16 Nov 2025 — SOU EXTENSION 5 FILED
- 02 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 23 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 23 Jan 2026 — PETITION TO REVIVE-GRANTED
- 23 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 21 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Jan 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Dec 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Dec 2025 — ABANDONMENT - NO USE STATEMENT FILED